Administration of nifedipine CR immediately after awakening prevents a morning surge in hypertensive patients. Case report of three cases.

Hiroaki Kawano, Naoto Ashizawa, Genji Toda, Shinji Seto, Katsusuke Yano
{"title":"Administration of nifedipine CR immediately after awakening prevents a morning surge in hypertensive patients. Case report of three cases.","authors":"Hiroaki Kawano,&nbsp;Naoto Ashizawa,&nbsp;Genji Toda,&nbsp;Shinji Seto,&nbsp;Katsusuke Yano","doi":"10.1080/08038020310000113","DOIUrl":null,"url":null,"abstract":"<p><p>Although the blood pressure-lowering action of some long-acting calcium antagonists may last more than 24 h, some patients taking this drug still experience a morning surge, i.e. an early morning increase in blood pressure. We evaluated this morning surge in three hypertensive patients with morning surge after administration of antihypertensive drugs including nifedipine CR. Nifedipine CR is one of the once-a-day formulations of nifedipine, which after administration, results in two peaks in the plasma concentration of nifedipine. The first concentration peak of occurs 3 h after administration and the second around 12 h after intake. When the time of intake of nifedipine CR was changed from after breakfast to immediately after awakening, the morning surge was suppressed in these patients without the use of other drugs such as alpha- or beta-blockers. Administration of nifedipine CR immediately after awakening is one option that can be used to prevent morning surge as well as to control blood pressure throughout the day.</p>","PeriodicalId":8974,"journal":{"name":"Blood pressure. Supplement","volume":"1 ","pages":"44-8"},"PeriodicalIF":0.0000,"publicationDate":"2003-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/08038020310000113","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood pressure. Supplement","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/08038020310000113","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

Although the blood pressure-lowering action of some long-acting calcium antagonists may last more than 24 h, some patients taking this drug still experience a morning surge, i.e. an early morning increase in blood pressure. We evaluated this morning surge in three hypertensive patients with morning surge after administration of antihypertensive drugs including nifedipine CR. Nifedipine CR is one of the once-a-day formulations of nifedipine, which after administration, results in two peaks in the plasma concentration of nifedipine. The first concentration peak of occurs 3 h after administration and the second around 12 h after intake. When the time of intake of nifedipine CR was changed from after breakfast to immediately after awakening, the morning surge was suppressed in these patients without the use of other drugs such as alpha- or beta-blockers. Administration of nifedipine CR immediately after awakening is one option that can be used to prevent morning surge as well as to control blood pressure throughout the day.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
醒后立即给予硝苯地平CR可防止高血压患者晨涌。三例病例报告。
虽然一些长效钙拮抗剂的降血压作用可能持续24小时以上,但一些服用此药的患者仍然会出现清晨血压升高的现象。我们评估了3例高血压患者在服用硝苯地平CR等降压药后出现晨起。硝苯地平CR是硝苯地平的一种每日一次的剂型,给药后会导致硝苯地平的血药浓度出现两个高峰。第一个浓度峰出现在给药后3小时,第二次浓度峰出现在服药后12小时左右。当硝苯地平CR的摄入时间由早餐后改为醒来后立即服用时,无需使用α -受体阻滞剂或β -受体阻滞剂等其他药物即可抑制晨起。醒来后立即服用硝苯地平是一种选择,可以用来防止晨起高潮,也可以控制全天的血压。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Post-registration studies for the evaluation of antihypertensive drugs. Effect of fixed dose combinations of metoprolol and amlodipine in essential hypertension: MARS--a randomized controlled trial. Efficacy and safety of valsartan in hypertensive Taiwanese patients: post-marketing surveillance study. Efficacy and safety of early versus late titration of fixed-dose irbesartan/hydrochlorothiazide: ACTUAL study. Clevidipine for severe hypertension in patients with renal dysfunction: a VELOCITY trial analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1